Marion Wealth Management Has $2.80 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Marion Wealth Management lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,221 shares of the financial services provider’s stock after acquiring an additional 792 shares during the quarter. Marion Wealth Management’s holdings in iShares Biotechnology ETF were worth $2,799,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. BNP Paribas Financial Markets grew its stake in shares of iShares Biotechnology ETF by 25.7% during the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the last quarter. Main Management ETF Advisors LLC lifted its holdings in iShares Biotechnology ETF by 2.6% during the 2nd quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock worth $79,451,000 after buying an additional 14,535 shares in the last quarter. Global Assets Advisory LLC bought a new position in iShares Biotechnology ETF in the 1st quarter valued at $66,059,000. Raymond James Financial Services Advisors Inc. increased its stake in shares of iShares Biotechnology ETF by 24.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after buying an additional 42,822 shares during the period. Finally, Commonwealth Equity Services LLC increased its stake in shares of iShares Biotechnology ETF by 5.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 198,709 shares of the financial services provider’s stock valued at $27,267,000 after buying an additional 10,033 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.2 %

Shares of IBB opened at $142.18 on Tuesday. The stock’s fifty day simple moving average is $145.37 and its 200-day simple moving average is $139.17. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.